Filing Details
- Accession Number:
- 0001127602-16-054884
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-07 12:56:11
- Reporting Period:
- 2016-06-03
- Filing Date:
- 2016-06-07
- Accepted Time:
- 2016-06-07 12:56:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341125 | Richard Kuntz | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Srvp & Chief Scien, Clin, Reg | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2016-06-03 | 23,028 | $47.77 | 127,647 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2016-06-03 | 35,872 | $36.24 | 163,519 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2016-06-03 | 49,905 | $82.60 | 113,614 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2016-06-03 | 23,028 | $0.00 | 23,028 | $47.77 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2016-06-03 | 35,872 | $0.00 | 35,872 | $36.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-10-29 | No | 4 | M | Direct | |
0 | 2018-10-27 | No | 4 | M | Direct |
Footnotes
- The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $82.42 to $82.865, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.
- This balance increased by 261 shares due to exempt transactions such as dividend reinvestment.
- These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.